For me its all about sentiment still. The share price won't run up significantly yet until the following things are out of the way.
Inflation needs to be under control.
Intrest rate cycle needs to have reached its end.
The threat of recession gone or have a recession and be moving back to growth.
China's growth needs to be stable and providing certainty of recovery.
This is what's needed as the rest is in place
low copper inventories already on global metal exchanges.
solid resource and preliminary financials for HCH.
growing demand for copper.
The Royalty deal that has been done in my eyes was a very strategic move it provides stability for HCH to get through to 2025 with all going to plan the issues above will be resolved the copper price will be higher PFS complete more resource added.
Any further negotiations in regards to CR, Royalty or streaming will be done form a position of strength for HCH.
A steady build on the SP from here is ok the real moment will be late 2024 to 2025.
- Forums
- ASX - By Stock
- HCH
- Ann: HCH Closes US$15 Million Investment by Osisko Gold Royalties
Ann: HCH Closes US$15 Million Investment by Osisko Gold Royalties, page-47
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCH (ASX) to my watchlist
|
|||||
Last
96.0¢ |
Change
0.015(1.59%) |
Mkt cap ! $145.2M |
Open | High | Low | Value | Volume |
95.5¢ | 98.5¢ | 94.5¢ | $87.27K | 91.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6000 | 95.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.5¢ | 7010 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 19600 | 0.940 |
2 | 10042 | 0.935 |
8 | 21572 | 0.930 |
4 | 16731 | 0.925 |
1 | 5500 | 0.920 |
Price($) | Vol. | No. |
---|---|---|
0.965 | 7010 | 3 |
0.990 | 10000 | 1 |
0.995 | 35000 | 1 |
1.000 | 10371 | 2 |
1.010 | 3000 | 1 |
Last trade - 15.57pm 15/07/2024 (20 minute delay) ? |
Featured News
HCH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online